EPCAM and neoplasm: The sensitivity of the assay was high enough to detect tumour associated antigens, such as EpCAM from H3122 lung cancer-derived EVs, at a concentration of 3.125 × 106 EVs/μl in plasma (Additional file 1: Fig. S8A).